MHMasanori Hirashima

Masanori Hirashima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masanori Hirashima has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Hitomi Kondo

    Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Hadano, Japan

    2 shared publications
  • Kenji Takanobu

    Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Hadano, Japan

    2 shared publications
  • Kenzo Okamoto

    Department of Pathology, Hokkaido Chuo Rosai Hospital, Japan Organization of Occupational Health and Safety, Iwamizawa, Japan

    2 shared publications
  • Kyohei Misumi

    Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Hadano, Japan

    2 shared publications
  • Masaaki Suzuki

    Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Hadano, Japan

    2 shared publications
  • Misae Saito

    Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Hadano, Japan

    2 shared publications

Latest Publications

  • Open Access

    Correction to: Dose–response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats

    by Tomoki Takeda, Shotaro Yamano, Yuko Goto, Shigeyuki Hirai, Yusuke Furukawa, Yoshinori Kikuchi, Kyohei Misumi, Masaaki Suzuki, Kenji Takanobu, Hideki Senoh, et al.

  • Open Access

    Hypoxia-induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain

    by Marlene E. Da Vitoria Lobo, Nick Weir, Lydia Hardowar, Yara Al Ojaimi, Ryan Madden, Alex Gibson, Samuel M. Bestall, Masanori Hirashima, Chris B. Schaffer, Lucy F. Donaldson, et al.

    Neuropathic pain, such as that seen in diabetes mellitus, results in part from central sensitisation in the dorsal horn. However, the mechanisms responsible for such sensitisation remain unclear. There is evidence that disturbances in the integrity of the spinal vascular network can be causative factors in the development of neuropathic pain. Here we show that reduced blood flow and vascularity of the dorsal horn leads to the onset of neuropathic pain. Using rodent models (type 1 diabetes and an inducible endothelial-specific vascular endothelial growth factor receptor 2 knockout mouse) that result in degeneration of the endothelium in the dorsal horn, we show that spinal cord vasculopathy results in nociceptive behavioural hypersensitivity. This also results in increased hypoxia in dorsal horn neurons, depicted by increased expression of hypoxia markers such as hypoxia inducible factor 1α, glucose transporter 3, and carbonic anhydrase 7. Furthermore, inducing hypoxia through intrathecal delivery of dimethyloxalylglycine leads to the activation of dorsal horn neurons as well as mechanical and thermal hypersensitivity. This shows that hypoxic signalling induced by reduced vascularity results in increased hypersensitivity and pain. Inhibition of carbonic anhydrase activity, through intraperitoneal injection of acetazolamide, inhibited hypoxia-induced pain behaviours. This investigation demonstrates that induction of a hypoxic microenvironment in the dorsal horn, as occurs in diabetes, is an integral process by which neurons are activated to initiate neuropathic pain states. This leads to the conjecture that reversing hypoxia by improving spinal cord microvascular blood flow could reverse or prevent neuropathic pain.


  • Open Access

    Dose-response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats

    by Tomoki Takeda, Shotaro Yamano, Yuko Goto, Shigeyuki Hirai, Yusuke Furukawa, Yoshinori Kikuchi, Kyohei Misumi, Masaaki Suzuki, Kenji Takanobu, Hideki Senoh, et al.

    Background: In Japan, six workers handling cross-linked water-soluble acrylic acid polymer (CWAAP) at a chemical plant suffered from lung diseases, including fibrosis, interstitial pneumonia, emphysema, and pneumothorax. We recently demonstrated that inhalation of CWAAP-A, one type of CWAAP, causes pulmonary disorders in rats. It is important to investigate dose-response relationships and recoverability from exposure to CWAAPs for establishing occupational health guidelines, such as setting threshold limit value for CWAAPs in the workplace. Methods: Male and female F344 rats were exposed to 0.3, 1, 3, or 10 mg/m 3 CWAAP-A for 6 hours/day, 5 days/week for 13 weeks using a whole-body inhalation exposure system. At 1 hour, 4 weeks, and 13 weeks after the last exposure the rats were euthanized and blood, bronchoalveolar lavage fluid, and all tissues including lungs and mediastinal lymph nodes were collected and subjected to biological and histopathological analyses. In a second experiment, male rats were pre-treated with clodronate liposome or polymorphonuclear leukocyte-neutralizing antibody to deplete macrophages or neutrophils, respectively, and exposed to CWAAP-A for 6 hours/day for 2 days. Results: CWAAP-A exposure damaged only the alveoli. The lowest observed adverse effect concentration (LOAEC) was 1 mg/m 3 and the no observed adverse effect concentration (NOAEC) was 0.3 mg/m 3 . Rats of both sexes were able to recover from the tissue damage caused by 13 weeks exposure to 1 mg/m 3 CWAAP-A. In contrast, tissue damage caused by exposure to 3 and 10 mg/m 3 was irreversible due to the development of interstitial lung lesions. There was a gender difference in the recovery from CWAAP-A induced pulmonary disorders, with females recovering less than males. Finally, acute lung effects caused by CWAAP-A were significantly reduced by depletion of alveolar macrophages. Conclusions: Pulmonary damage caused by inhalation exposure to CWAAP-A was dose-dependent, specific to the lung and lymph nodes, and acute lung damage was ameliorated by depleting macrophages in the lungs. CWAAP-A had both a LOAEC and a NOAEC, and tissue damage caused by exposure to 1 mg/m 3 CWAAP-A was reversible: recovery in female rats was less than for males. These findings indicate that concentration limits for CWAAPs in the workplace can be determined.

  • Open Access

    Regulation of dermal lymphatic vascular formation by blood vessel-related factors

    by Masanori Hirashima

    Development of lymphatic endothelial cells (LECs) and subsequent formation of lymphatic vasculature are highly related to blood vessels. Previous studies indicated that lymphatic vascular patterning is regulated, at least in part, by blood vessel-related factors. LECs are differentiated from venous endothelial cells and migrate adjacent to arteries toward peripheral tissues, such as the skin. Following migration along arteries, LECs should eventually be repelled from blood vessels to form a random lymphatic vascular network. We previously showed that this repulsive migration is regulated by the artery-derived guidance factor Semaphorin 3G. Lymphatic vasculature in adults is separate from blood vessels except for physiological lymph-venous connection sites at the venous angle and is free of blood cells, such as erythrocytes and platelets. Here I will discuss a possible role and molecular mechanism of platelets in partitioning blood and lymphatic vascular compartments by promoting LEC retraction in mouse embryonic skin.

  • Open Access

    PKN2 is essential for mouse embryonic development and proliferation of mouse fibroblasts

    by Sally Danno, Koji Kubouchi, Mona Mehruba, Manabu Abe, Rie Natsume, Kenji Sakimura, Satoshi Eguchi, Masahiro Oka, Masanori Hirashima, Hiroki Yasuda, et al.

    PKN2, a member of the protein kinase N (PKN) family, has been suggested by in vitro culture cell experiments to bind to Rho/Rac GTPases and contributes to cell–cell contact and cell migration. To unravel the in vivo physiological function of PKN2, we targeted the PKN2 gene. Constitutive disruption of the mouse PKN2 gene resulted in growth retardation and lethality before embryonic day (E) 10.5. PKN2−/− embryo did not undergo axial turning and showed insufficient closure of the neural tube. Mouse embryonic fibroblasts (MEFs) derived from PKN2−/− embryos at E9.5 failed to grow. Cre‐mediated ablation of PKN2 in PKN2flox/flox MEFs obtained from E14.5 embryos showed impaired cell proliferation, and cell cycle analysis of these MEFs showed a decrease in S‐phase population. Our results show that PKN2 is essential for mouse embryonic development and cell‐autonomous proliferation of primary MEFs in culture. Comparison of the PKN2−/− phenotype with the phenotypes of PKN1 and PKN3 knockout strains suggests that PKN2 has distinct nonredundant functions in vivo, despite the structural similarity and evolutionary relationship among the three isoforms.